This week, the Department of Health and Human Services officially approved Geary Community Hospital's application to participate in the 340B Drug Pricing Program, allowing the hospital to save thousands of dollars in pharmaceutical costs.
"Geary Community Hospital qualified for a federal program under which it would begin receiving significant savings on pharmaceutical purchases of up 70 percent starting on October 1, 2020," said Richard Lews, Chief Financial Officer for Geary Community Hospital. "GCH requested a waiver granting it early entry into the program. With Representative Marshall's advocacy, GCH waiver request was granted effective today, July 20, 2020 allowing GCH to reduce its pharmaceutical costs immediately by tens of thousands of dollars every month. These savings will be used to better serve GCH's patients in both its clinics and the hospital proper. GCH appreciates Representative Marshall's willingness to assist at a crucial time."
Rep. Marshall has been a strong proponent of the 340B program since coming to Congress and has been a tireless advocate for its continuation. The program helps health care entities -- including rural hospitals - realize substantial savings in prescription drugs costs, which allows them to use these savings toward other vital programs and core operational costs.
"It is vital we do all we can to support our rural hospitals," said Rep. Marshall. "As a physician and now a member of Congress, it is my goal to ensure hospitals in Kansas are connected with the programs and resources necessary to continue serving their communities. We cannot let our hospitals suffer unnecessary costs and regulations."